psychiatric diseases (O'Reilly et al., 1965; Sohler et al., 1967; Irvine, 1974) . Tentatively identified as 3-ethyl-2,4-dimethylpyrrole (kryptopyrrole) (Irvine et al., 1969; Sohler et al., 1970) the metabolite was also shown to be excreted by a percentage of patients with hepatic porphyria and also schizophrenics who showed abnormally high porphyrin excretion. These latter findings initiated studies on the effects of krypropyrrole on porphyrin metabolism, and it was shown that in bacterial cultures (Berek et al., 1975) and in the rat (Brodie et al., 1976) synthetic kryptopyrrole increased porphyrin synthesis and excretion.
Re-identification of the metabolite in the urine (Irvine, 1974) as 4-ethyl-5-hydroxy-3,5-dimethyl-A3-pyrrolin-2-one (5-hydroxykryptopyrrolen-2-one) or its 88' isomer led to a study of the effects of this compound on porphyrin synthesis .
This was also shown to increase porphyrin synthesis and excretion in therat. The present study was designed to further investigate the effects of 5-hydroxykryptopyrrolen-2-one on haem metabolism in the rat. 5-Hydroxykryptopyrrolen-2-one was produced by the dye-sensitized photo-oxidation of kryptopyrrole by the method of Lightner & Crandall (1973) and was purified by recrystallization. Male Sprague-Dawley rats (200g body wt.) were injected (intraperitoneally) daily for 2 days as follows : the test group received 5-hydroxykryptopyrrolen-2-one (0.64mmol/kg) dissolved in O.5ml of aq. 50% (v/v) ethanol whereas the control group was injected with 0.5ml of ethanol alone. Both groups of animals were allowed food and water ad libitum. On the third day the animals were killed, and the livers removed and kept on ice for immediate enzyme analysis and for the preparation of a microsomal fraction.
The activities of the enzymes of haem biosynthesis, 6-aminolaevulinate synthase EC 2.3.1.37), 8-aminolaevulinate dehydratase (EC 4.2.1.24), porphobilinogen deamin-570th MEETING, CARDIFF The results were analysed by using the standard t test. Table 1 shows that treatment with 5-hydroxykryptopyrrolen-2-one results in a significant increase in 6-aminolaevulinate synthase activity, the rate-determining enzyme of haem biosynthesis. The activities of the other enzymes of the pathway are not significantlydifferent fromcontrol values. Thiseffect ismost likely to bedue toinductioncaused by decreased hepatic haem concentrations, amounts of both microsomal haem and cytochrome P-450 being significantly lowered ( P < 0.01) by 5-hydroxykryptopyrrolen-2-one treatment (Table 2) . These results, however, do not explain the increase in excretion of formed porphyrins by animals treated with S-hydroxykryptopyrrolen-2-one shown in previous work , although this may be due to the increased activity of the pathway. The mechanism by which S-hydroxykryptopyrrolen-2-one causes a decrease in haem concentrations remains to be elucidated. The results given here may be of significance in the hepatic porphyrias, although it is now almost certain that the form present is the 88' isomer of S-hydroxykryptopyrrolenVol. 5
